These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25856504)

  • 1. Elevated plasma CXCL12α is associated with a poorer prognosis in pulmonary arterial hypertension.
    McCullagh BN; Costello CM; Li L; O'Connell C; Codd M; Lawrie A; Morton A; Kiely DG; Condliffe R; Elliot C; McLoughlin P; Gaine S
    PLoS One; 2015; 10(4):e0123709. PubMed ID: 25856504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated plasma YKL-40 as a prognostic indicator in patients with idiopathic pulmonary arterial hypertension.
    Chen G; Yang T; Gu Q; Ni XH; Zhao ZH; Ye J; Meng XM; Liu ZH; He JG; Xiong CM
    Respirology; 2014 May; 19(4):608-15. PubMed ID: 24689969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors of pulmonary hypertension associated with connective tissue disease: pulmonary artery size measured by chest CT.
    Li X; Zhang C; Sun X; Yang X; Zhang M; Wang Q; Zhu Y
    Rheumatology (Oxford); 2020 Nov; 59(11):3221-3228. PubMed ID: 32221604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival in rheumatoid arthritis-associated pulmonary arterial hypertension compared with idiopathic pulmonary arterial hypertension.
    Sadeghi S; Granton JT; Akhavan P; Pasarikovski CR; Roos AM; Thenganatt J; Moric J; Johnson SR
    Respirology; 2015 Apr; 20(3):481-7. PubMed ID: 25583377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated Levels of Circulating Bone Morphogenetic Protein 7 Predict Mortality in Pulmonary Arterial Hypertension.
    Liu D; Wu BX; Sun N; Yan Y; Yuan P; Qu JM; Jing ZC
    Chest; 2016 Aug; 150(2):367-73. PubMed ID: 27001265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet distribution width and mean platelet volume in idiopathic pulmonary arterial hypertension.
    Zheng YG; Yang T; Xiong CM; He JG; Liu ZH; Gu Q; Zhao ZH; Ni XH
    Heart Lung Circ; 2015 Jun; 24(6):566-72. PubMed ID: 25573235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct bilirubin: A new risk factor of adverse outcome in idiopathic pulmonary arterial hypertension.
    Xu XQ; Lv ZC; Liu QQ; Zhao QH; Wu Y; Sun K; Jiang X; Wang L; Peng FH; Jing ZC
    Int J Cardiol; 2017 Feb; 228():895-899. PubMed ID: 27894061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline Characteristics of the Korean Registry of Pulmonary Arterial Hypertension.
    Chung WJ; Park YB; Jeon CH; Jung JW; Ko KP; Choi SJ; Seo HS; Lee JS; Jung HO;
    J Korean Med Sci; 2015 Oct; 30(10):1429-38. PubMed ID: 26425039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis and response to first-line single and combination therapy in pulmonary arterial hypertension.
    Kylhammar D; Persson L; Hesselstrand R; Rådegran G
    Scand Cardiovasc J; 2014 Aug; 48(4):223-33. PubMed ID: 24912571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and Survival of Anti-U1 RNP Antibody-Positive Patients With Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.
    Sobanski V; Giovannelli J; Lynch BM; Schreiber BE; Nihtyanova SI; Harvey J; Handler CE; Denton CP; Coghlan JG
    Arthritis Rheumatol; 2016 Feb; 68(2):484-93. PubMed ID: 26415038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary venous occlusion and death in pulmonary arterial hypertension: survival analyses using radiographic surrogates.
    Takeda Y; Takeda Y; Yamamoto K; Tomimoto S; Tani T; Narita H; Ohte N; Kimura G
    BMC Pulm Med; 2011 Oct; 11():47. PubMed ID: 21974838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased platelet content of SDF-1alpha is associated with worse prognosis in patients with pulmonary prterial hypertension.
    Kazimierczyk R; Blaszczak P; Jasiewicz M; Knapp M; Ptaszynska-Kopczynska K; Sobkowicz B; Waszkiewicz E; Grzywna R; Musial WJ; Kaminski KA
    Platelets; 2019; 30(4):445-451. PubMed ID: 29617176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Right atrial function for the prediction of prognosis in connective tissue disease-associated pulmonary arterial hypertension: a study with two-dimensional speckle tracking.
    Bai Y; Yang J; Liu J; Ning H; Zhang R
    Int J Cardiovasc Imaging; 2019 Sep; 35(9):1637-1649. PubMed ID: 31037473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating NEDD9 is increased in pulmonary arterial hypertension: A multicenter, retrospective analysis.
    Samokhin AO; Hsu S; Yu PB; Waxman AB; Alba GA; Wertheim BM; Hopkins CD; Bowman F; Channick RN; Nikolic I; Faria-Urbina M; Hassoun PM; Leopold JA; Tedford RJ; Ventetuolo CE; Leary PJ; Maron BA
    J Heart Lung Transplant; 2020 Apr; 39(4):289-299. PubMed ID: 31952977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
    Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
    [No Abstract]   [Full Text] [Related]  

  • 16. Soluble Receptor for Advanced Glycation End Products (sRAGE) Is a Sensitive Biomarker in Human Pulmonary Arterial Hypertension.
    Diekmann F; Chouvarine P; Sallmon H; Meyer-Kobbe L; Kieslich M; Plouffe BD; Murthy SK; Lichtinghagen R; Legchenko E; Hansmann G
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Comparison of Demographic, Hemodynamic, and MRI Characteristics and Outcomes.
    Ramjug S; Hussain N; Hurdman J; Billings C; Charalampopoulos A; Elliot CA; Kiely DG; Sabroe I; Rajaram S; Swift AJ; Condliffe R
    Chest; 2017 Jul; 152(1):92-102. PubMed ID: 28223154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Insights from a referral center in Portugal.
    Santos M; Gomes A; Cruz C; Rocha J; Ricardo M; Gonçalves F; Carvalho L; Vicente M; Melo A; Reis A
    Rev Port Cardiol (Engl Ed); 2018 Sep; 37(9):749-757. PubMed ID: 30144959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-3 and aldosterone as potential tandem biomarkers in pulmonary arterial hypertension.
    Calvier L; Legchenko E; Grimm L; Sallmon H; Hatch A; Plouffe BD; Schroeder C; Bauersachs J; Murthy SK; Hansmann G
    Heart; 2016 Mar; 102(5):390-6. PubMed ID: 26869635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Cell-Free DNA Predicts Survival and Maps Specific Sources of Injury in Pulmonary Arterial Hypertension.
    Brusca SB; Elinoff JM; Zou Y; Jang MK; Kong H; Demirkale CY; Sun J; Seifuddin F; Pirooznia M; Valantine HA; Tanba C; Chaturvedi A; Graninger GM; Harper B; Chen LY; Cole J; Kanwar M; Benza RL; Preston IR; Agbor-Enoh S; Solomon MA
    Circulation; 2022 Oct; 146(14):1033-1045. PubMed ID: 36004627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.